1. Comparison of two-dimensional (2D)- and three-dimensional (3D)-culture models as drug testing platforms in GIST: experience with axitinib in vitro. (February 2017) Authors: Martínez-Marín, V.; Redondo, A.; Heredia, V.; Guerra, L.; Miguel-Martín, M.; Crespo, R.; Hardisson, D.; Feliu, J.; Mendiola, M. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Experience with Endopredict® implementation at La Paz Universitiy Hospital (2015–2018). (March 2019) Authors: Frias, L.; Pelaez-Garcia, A.; Berjon, A.; Yebenes, L.; Zamora, P.; Sousa-Faro, M.; Marti, C.; Mendiola, M.; Sanchez-Mendez, J.I.; Hardisson, D. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The hallmarks of ovarian cancer: Focus on angiogenesis and micro-environment and new models for their characterisation. (August 2020) Authors: Heredia-Soto, V.; López-Guerrero, J.A.; Redondo, A.; Mendiola, M. Journal: EJC supplements Issue: Volume 15(2020) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗